Below is an overview of companies of note which are currently operating in the German market. This list is indicative and not exhaustive.
Bedrocan is a producer of legal medicinal cannabis. It is Germany’s main cannabis importer (1,500 kilograms in 2018). The company’s headquarters are in the Netherlands.
Canopy Growth is a Canadian licensed producer that specialises in cannabis dried flower, oils, concentrates, softgel capsules and hemp. Canopy Growth was the first company to obtain a licence to produce medicinal cannabis for Germany via its subsidiary Spektrum Cannabis GmbH. In December, Canopy Growth acquired the Tuttlinger Storz & Bickel GmbH, manufacturer of medically licensed vaporisers. Canopy Growth created its German base two years ago with the acquisition of MedCann in St. Leon-Rot near Heidelberg. In May 2019, Canopy acquired German-based, Bionorica SE-founded C3 Cannabinoid Compound Company ("C3") for €225.9 million
Cannamedical Pharma GmbH is a leading, independent medical cannabis wholesaler and distributor of high quality medicinal cannabis products to pharmacies and clinical facilities. In September 2019, Cannamedical was the first company to successfully import medicinal cannabis from Portugal to Germany
Aurora Cannabis Inc. is a Canadian licensed cannabis producer, headquartered in Edmonton. In operation since 2016, Aurora sells dried cannabis, oils and softgels for medical purposes. Aurora owns subsidiaries such as Anandia Laboratories, CanniMed, and CanvasRx and has received one of the domestic cannabis licences in Germany to produce cannabis in Germany.
Cronos Group is a diversified and vertically integrated Canadian-based cannabis company. Cronos has entered into a strategic distribution partnership with G. Pohl-Boskamp GmbH &, an international pharmaceutical manufacturer and supplier, distributing its products to over 12,000 pharmacies in Germany alone
Aphria is a licensed medical cannabis producer based in Canada. Aphria bought CC Pharma GmbH, based in Densborn in Rhineland-Palatinate for €18.92 million. This gives Aphria access to the 13,000 pharmacies in Germany that source pharmaceutical products from CC Pharma. Aphria has received a domestic cultivation licence authorisation.
Wayland has grown and harvested hemp in Ebersbach, north of Dresden, for commercial use for the first time. Wayland Group provides medical cannabis with sustainable cannabis cultivation. Wayland has been awarded a cultivation licence through its joint venture with Demecan. Demecan have completed a €7 million funding round in October 2019.
Tilray is a global GMP-certified supplier of medical cannabis (dried cannabis or extracts). Tilray partners with hospitals and universities to promote cannabinoid research.